logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9388134 B1

PDFFull Text
Date of Patent:
Jul. 12, 2016

Filed:

Jun. 23, 2014

Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations

Applicants:

Lili Feng, Pine Brook, NJ (US);

Sven Erik Godtfredsen, Chatham, NJ (US);

Paul Allen Sutton, Parsippany, NJ (US);

Mahavir Prashad, Montville, NJ (US);

Michael J. Girgis, Montville, NJ (US);

Bin HU, Green Brook, NJ (US);

Yugang Liu, Bridgewater, NJ (US);

Thomas J. Blacklock, East Hanover, NJ (US);

Piotr Henryk Karpinski, Lincoln Park, NJ (US);

Inventors:

Lili Feng, Pine Brook, NJ (US);

Sven Erik Godtfredsen, Chatham, NJ (US);

Paul Allen Sutton, Parsippany, NJ (US);

Mahavir Prashad, Montville, NJ (US);

Michael J. Girgis, Montville, NJ (US);

Bin Hu, Green Brook, NJ (US);

Yugang Liu, Bridgewater, NJ (US);

Thomas J. Blacklock, East Hanover, NJ (US);

Piotr Henryk Karpinski, Lincoln Park, NJ (US);

Assignee:

NOVARTIS, AG, Basel, CH;

Attorney:

David R. Kurlandsky

Primary Examiner:

Timothy Thomas

Int. Cl.
CPC ...
A61K 31/41 (2006.01); C07D 207/50 (2006.01); A61K 31/216 (2006.01); A61K 45/06 (2006.01); A61K 31/4422 (2006.01); A61K 31/5415 (2006.01); C07C 233/47 (2006.01); C07D 257/04 (2006.01);
U.S. Cl.
CPC ...
C07D 207/50 (2013.01); A61K 31/216 (2013.01); A61K 31/41 (2013.01); A61K 31/4422 (2013.01); A61K 31/5415 (2013.01); A61K 45/06 (2013.01); C07C 233/47 (2013.01); C07D 257/04 (2013.01); A61K 2300/00 (2013.01);
Abstract

A method for treatment of a cardiovascular or renal condition or disease with a specific combination, linked pro-drug or a compound of an angiotensin receptor antagonist and a NEPi.

Find Patent Forward Citations

Feng, Lili. (2016). Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations (U.S. Patent No. 9388134). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9388134

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…